Lindsay L Devane

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC514
405B
173 Ashley Ave.
Phone843-792-5448
Fax843-792-6318
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lindsay DeVane C. Women's Pharmacotherapy Matters. Pharmacotherapy. 2016 09; 36(9):953-4. PMID: 27650803.
      Citations:    
    2. DeVane CL. Honoring Pharmacotherapy's Editorial Board. Pharmacotherapy. 2016 Jan; 36(1):11-2. PMID: 26799346.
      Citations:    
    3. DeVane CL. The Art and Science of Reviewing the Pharmacotherapy Literature. Pharmacotherapy. 2015 Nov; 35(11):981-2. PMID: 26598089.
      Citations:    
    4. DeVane CL. An epidemic of opioid prescriptions. Pharmacotherapy. 2015 Mar; 35(3):241-2. PMID: 25809174.
      Citations:    
    5. DeVane CL. Behind the cover at Pharmacotherapy. Pharmacotherapy. 2014 Feb; 34(2):109-11. PMID: 24523095.
      Citations:    
    6. DeVane L, Goetzl LM, Ramamoorthy S. Exposing fetal drug exposure. Clin Pharmacol Ther. 2011 Jun; 89(6):786-8. PMID: 21593755.
      Citations:    
    7. DeVane CL. Antidepressant-drug interactions are potentially but rarely clinically significant. Neuropsychopharmacology. 2006 Aug; 31(8):1594-604; discussion 1614-5. PMID: 16847446.
      Citations:    
    8. DeVane CL, Donovan JL, Liston HL, Markowitz JS, Cheng KT, Risch SC, Willard L. Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers. J Clin Psychopharmacol. 2004 Feb; 24(1):4-10. PMID: 14709940.
      Citations:    
    9. DeVane CL. Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea. J Clin Psychiatry. 2003; 64 Suppl 18:14-9. PMID: 14700450.
      Citations:    
    10. DeVane CL, Mintzer J. Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update. Psychopharmacol Bull. 2003; 37(4):116-32. PMID: 15131522.
      Citations:    
    11. DeVane CL. Pharmacokinetics, drug interactions, and tolerability of valproate. Psychopharmacol Bull. 2003; 37 Suppl 2:25-42. PMID: 14624231.
      Citations:    
    12. DeVane CL, Grothe DR, Smith SL. Pharmacology of antidepressants: focus on nefazodone. J Clin Psychiatry. 2002; 63 Suppl 1:10-7. PMID: 11890560.
      Citations:    
    13. DeVane CL. Clinical significance of drug binding, protein binding, and binding displacement drug interactions. Psychopharmacol Bull. 2002; 36(3):5-21. PMID: 12473961.
      Citations:    
    14. DeVane CL, Liston HL, Markowitz JS. Clinical pharmacokinetics of sertraline. Clin Pharmacokinet. 2002; 41(15):1247-66. PMID: 12452737.
      Citations:    
    15. DeVane CL, Markowitz JS. Psychoactive drug interactions with pharmacotherapy for diabetes. Psychopharmacol Bull. 2002; 36(2):40-52. PMID: 12397839.
      Citations:    
    16. DeVane CL. Substance P: a new era, a new role. Pharmacotherapy. 2001 Sep; 21(9):1061-9. PMID: 11560196.
      Citations:    
    17. DeVane CL, Nemeroff CB. An evaluation of risperidone drug interactions. J Clin Psychopharmacol. 2001 Aug; 21(4):408-16. PMID: 11476125.
      Citations:    
    18. DeVane CL, Nemeroff CB. Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin Pharmacokinet. 2001; 40(7):509-22. PMID: 11510628.
      Citations:    
    19. DeVane CL, Markowitz JS, Liston HL, Risch SC. Charleston Antidepressant Drug Interactions Surveillance Program (CADISP). Psychopharmacol Bull. 2001; 35(2):50-61. PMID: 12397886.
      Citations:    
    20. DeVane CL, Markowitz JS, Carson SW, Boulton DW, Gill HS, Nahas Z, Risch SC. Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizers. J Clin Psychopharmacol. 2000 Jun; 20(3):347-9. PMID: 10831022.
      Citations:    
    21. DeVane CL. Pharmacologic characteristics of ideal antidepressants in the 21st century. J Clin Psychiatry. 2000; 61 Suppl 11:4-8. PMID: 10926049.
      Citations:    
    22. DeVane CL, Simpkins JW, Boulton DW, Laizure SC, Miller RL. Disposition of morphine in tissues of the pregnant rat and foetus following single and continuous intraperitoneal administration to the mother. J Pharm Pharmacol. 1999 Nov; 51(11):1283-7. PMID: 10632086.
      Citations:    
    23. DeVane CL, Boulton DW, Miller LF, Miller RL. Pharmacokinetics of trazodone and its major metabolite m-chlorophenylpiperazine in plasma and brain of rats. Int J Neuropsychopharmacol. 1999 Mar; 2(1):17-23. PMID: 11281966.
      Citations:    
    24. DeVane CL. Differential pharmacology of newer antidepressants. J Clin Psychiatry. 1998; 59 Suppl 20:85-93. PMID: 9881541.
      Citations:    
    Devane's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (130)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _